STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
165
13F, latest reported quarter
Conversions, 180 days
3
Codes C/M, not in net · $10.0M priced
What the filings say about AVPT
Insiders, 180 days
-$4.1M net sold
1 seller · 67% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$3.4M
8 notices
AvePoint insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, AvePoint, Inc. insiders sold a net $4.1M of stock across 97 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
38 earlier Form 4 trades (code P or S) here by this insider (38 sales), the last on Oct 20, 2026.
The trade is 15.6% of the 224,604 shares held after it.
No other insider sold within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Brown Brian Michael sold about $574.7K of AVPT under a 10b5-1 plan on Oct 23, 2026; 165 funds added in the latest 13F quarter.
37 earlier Form 4 trades (code P or S) here by this insider (37 sales), the last on Oct 16, 2026.
The trade is 28.0% of the 259,604 shares held after it.
No other insider sold within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Brown Brian Michael sold about $1.1M of AVPT under a 10b5-1 plan on Oct 20, 2026, the largest insider sale at the company since 2025; 165 funds added in the latest 13F quarter.
36 earlier Form 4 trades (code P or S) here by this insider (36 sales), the last on Oct 6, 2026.
The trade is 1.1% of the 332,210 shares held after it.
No other insider sold within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Brown Brian Michael sold about $53.2K of AVPT under a 10b5-1 plan on Oct 16, 2026; 165 funds added in the latest 13F quarter.
35 earlier Form 4 trades (code P or S) here by this insider (35 sales), the last on Sep 30, 2026.
The trade is 8.6% of the 335,710 shares held after it.
No other insider sold within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Brown Brian Michael sold about $437.7K of AVPT under a 10b5-1 plan on Oct 6, 2026; 165 funds added in the latest 13F quarter.
34 earlier Form 4 trades (code P or S) here by this insider (34 sales), the last on Sep 23, 2026.
The trade is 2.7% of the 364,604 shares held after it.
No other insider sold within 30 days.
165 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Brown Brian Michael sold about $141.1K of AVPT under a 10b5-1 plan on Sep 30, 2026; 165 funds added in the latest 13F quarter.
97 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
AVPT planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Brown Brian Michael
Filed 2026-10-23
$574.6K
Brown Brian Michael
Filed 2026-10-20
$1.1M
Brown Brian Michael
Filed 2026-10-16
$53.2K
Brown Brian Michael
Filed 2026-10-06
$437.7K
Brown Brian Michael
Filed 2026-09-30
$141.1K
AVPT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
WisdomTree Cloud Computing Fund
$3.5M position · as of 2026-06-30
1.4%
1290 Essex Small Cap Growth Fund
$1.2M position · as of 2026-07-31
1.0%
Kennedy Capital ESG SMID Cap Fund
$727.7K position · as of 2026-06-30
0.8%
State Street(R) SPDR(R) FactSet Innovative Technology ETF
$526.8K position · as of 2026-06-30
0.8%
State Street(R) SPDR(R) S&P(R) Software & Services ETF
$3.1M position · as of 2026-06-30
0.8%
THE HARTFORD SMALL COMPANY FUND
$4.9M position · as of 2026-07-31
0.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Dr. Tianyi Jiang
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.0M
$473.3K
$2.8M
+16%
+35%
2024
$3.0M
$16.0M
$2.4M
+35%
+26%
2023
$1.8M
$8.1M
$1.9M
-31%
+14%
2022
$2.2M
-$3.5M
$1.5M
-66%
-32%
2021
$6.8M
-$23.9M
$4.6M
-47%
+8%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.1M sold by insiders over 180 days, 165 funds added last quarter, $3.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$466.2M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM AVPT
FY Dec 2025
$419.5M
FY Dec 2024
$330.5M
FY Dec 2023
$271.8M
FY Dec 2022
$232.3M
FY Dec 2021
$191.9M
Jun 2026
$124.5M
Mar 2026
$117.2M
Dec 2025
$114.7M
Sep 2025
$109.7M
Jun 2025
$102.0M
Mar 2025
$93.1M
Dec 2024
$89.2M
Sep 2024
$88.8M
At each fiscal year end
Single quarter
Net margin, TTM
+15.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM AVPT
FY Dec 2025
+8.3%
FY Dec 2024
n/a
FY Dec 2023
-8.0%
FY Dec 2022
-17.9%
FY Dec 2021
-18.4%
Jun 2026
+22.1%
Mar 2026
+13.0%
Dec 2025
+13.6%
Sep 2025
+11.9%
Jun 2025
+2.6%
Mar 2025
+3.7%
Dec 2024
-19.3%
Sep 2024
+3.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$101.0M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM AVPT
FY Dec 2025
$81.6M
FY Dec 2024
$85.8M
FY Dec 2023
$32.6M
FY Dec 2022
-$4.6M
FY Dec 2021
$2.6M
Jun 2026
$14.7M
Mar 2026
$23.0M
Dec 2025
$29.0M
Sep 2025
$34.3M
Jun 2025
$19.3M
Mar 2025
-$1.0M
Dec 2024
$32.0M
Sep 2024
$30.8M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity AVPT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt AVPT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+16.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity AVPT
FY Dec 2025
+9.3%
FY Dec 2024
n/a
FY Dec 2023
-9.7%
FY Dec 2022
-17.4%
FY Dec 2021
-122.4%
Jun 2026
+16.2%
Mar 2026
+11.6%
Dec 2025
+9.3%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
-3.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets AVPT
FY Dec 2025
+5.3%
FY Dec 2024
n/a
FY Dec 2023
-5.1%
FY Dec 2022
-10.4%
FY Dec 2021
-12.6%
Jun 2026
+9.8%
Mar 2026
+7.0%
Dec 2025
+5.3%
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
-1.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -25%, not meaningful
Return on invested capital AVPT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+9.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed AVPT
FY Dec 2025
+8.1%
FY Dec 2024
+2.6%
FY Dec 2023
-5.7%
FY Dec 2022
-14.9%
FY Dec 2021
-30.2%
Jun 2026
+9.6%
Mar 2026
+9.8%
Dec 2025
+8.1%
Sep 2025
+6.1%
Jun 2025
+6.3%
Mar 2025
+4.3%
Dec 2024
+2.6%
Sep 2024
+1.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
51.44x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing AVPT
FY Dec 2025
86.81x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
35.03x
Mar 2026
45.29x
Dec 2025
86.81x
Sep 2025
8,652,676,024,015,781,888.00x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value AVPT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+2.9%
TTM free cash flow over market value at close 2026-10-27
FCF yield AVPT
FY Dec 2025
+2.7%
FY Dec 2024
+2.8%
FY Dec 2023
+2.2%
FY Dec 2022
-0.6%
FY Dec 2021
+0.2%
Jun 2026
+4.2%
Mar 2026
+5.2%
Dec 2025
+2.7%
Sep 2025
+2.7%
Jun 2025
+2.1%
Mar 2025
+2.7%
Dec 2024
+2.8%
Sep 2024
+3.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing AVPT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
AVPT ranks highest on profitability (76th percentile) and growth (74th), and lowest on insider conviction (29th), among Software & IT peers.
Profitability
76
Inputs
Return on equity+16.2% · 75 pct, sector of 286
Return on assets+9.8% · 81 pct, sector of 381
Return on invested capitaleffective tax rate -25%, not meaningful
Return on capital employed+9.6% · 71 pct, sector of 294
Growth
74
Inputs
Revenue growth, YoY+26.9% · 76 pct, sector of 480
Backlog growth, YoY+21.5% · 71 pct, sector of 182
Insider conviction
29
Inputs
Net Form 4 buying (codes P and S), 180d-$656K · 58 pct, sector of 284
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
66
Inputs
Funds adding, latest quarter165 · 66 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
48
Inputs
Short interest, % of float+8.5% · 33 pct, sector of 528
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+9.2% · 62 pct, sector of 316
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
AVPT filings, in plain words
Are AvePoint insiders buying or selling AVPT?
In the 180 days to 2026-10-28, AvePoint insiders were net sellers, a net $4.1M across purchases and sales reported on Form 4, by 1 seller.
Are there planned insider sales of AVPT?
Yes. 8 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $3.4M of stock; the latest, by Brown Brian Michael, was filed 2026-10-23.
Read the full summary
In the 180 days to 2026-10-28, AvePoint insiders were net sellers of AVPT, a net $4.1M across purchases and sales reported on Form 4 by 1 seller. 67% of the 12 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 8 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $3.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.